Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$7.96 - $13.59 $275,081 - $469,643
-34,558 Reduced 55.39%
27,828 $234,000
Q1 2024

May 15, 2024

SELL
$13.56 - $20.78 $2.59 Million - $3.97 Million
-190,917 Reduced 75.37%
62,386 $900,000
Q4 2023

Feb 14, 2024

SELL
$14.18 - $22.31 $1.77 Million - $2.78 Million
-124,717 Reduced 32.99%
253,303 $5.45 Million
Q3 2023

Nov 14, 2023

BUY
$18.22 - $25.85 $414,632 - $588,268
22,757 Added 6.41%
378,020 $7.27 Million
Q2 2023

Aug 14, 2023

BUY
$22.62 - $39.32 $2.71 Million - $4.72 Million
119,952 Added 50.98%
355,263 $9.03 Million
Q1 2023

May 15, 2023

BUY
$30.17 - $41.11 $676,833 - $922,261
22,434 Added 10.54%
235,311 $8.51 Million
Q4 2022

Feb 14, 2023

BUY
$36.43 - $49.4 $1.2 Million - $1.62 Million
32,845 Added 18.24%
212,877 $8.43 Million
Q3 2022

Nov 14, 2022

SELL
$40.66 - $53.03 $4.92 Million - $6.42 Million
-121,093 Reduced 40.21%
180,032 $8.39 Million
Q2 2022

Aug 15, 2022

BUY
$40.85 - $77.67 $3.09 Million - $5.87 Million
75,580 Added 33.51%
301,125 $13.2 Million
Q1 2022

May 16, 2022

BUY
$59.95 - $92.06 $2.21 Million - $3.4 Million
36,947 Added 19.59%
225,545 $16.3 Million
Q4 2021

Feb 14, 2022

BUY
$81.07 - $121.29 $15.3 Million - $22.9 Million
188,598 New
188,598 $15.3 Million
Q2 2021

Aug 16, 2021

SELL
$141.6 - $179.06 $2.01 Million - $2.54 Million
-14,173 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$132.81 - $182.18 $677,995 - $930,028
5,105 Added 56.3%
14,173 $1.98 Million
Q4 2020

Feb 16, 2021

BUY
$138.17 - $184.34 $1.25 Million - $1.67 Million
9,068 New
9,068 $1.57 Million
Q4 2019

Feb 14, 2020

SELL
$76.41 - $117.54 $1.87 Million - $2.88 Million
-24,532 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$61.52 - $91.1 $1.51 Million - $2.23 Million
24,532 New
24,532 $2.11 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $140M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.